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Abstract 32
Myokines are likely to be involved in the whole-body metabolic adaptive changes that 33
occur in response to regular exercise. We aimed to investigate the association of the two 34
myokines (adropin and apelin) with physical performance in professional soccer 35
players. To this purpose, we analyzed the fluctuations of circulating levels of both 36
adropin and apelin in professional soccer players during a season and evaluated the 37
possible association of these myokines with the performance level. Creatine kinase38
(CK) and lactate dehydrogenase (LDH) activity as well as iron, transferrin and high-39
sensitivity C-Reactive protein (hsCRP), ferritin, soluble transferrin receptor (sTfR), free 40
testosterone/cortisol ratio (FTCR), total iron binding capacity (TIBC) were also 41
determined. Fifteen male professional soccer players from an Italian Serie A team were 42
included in this study. Regarding the results of the biochemical analyses, the patterns of 43
changes in the biomarkers of fatigue and inflammation, i.e., HsCRP, CK and LDH 44
reflected the effects of the training throughout the season. No significant changes were 45
observed in adropin, while apelin exhibited variations that seem not to be related with 46
performance. In addition, both adropin and apelin did not represent valuable strategy to 47
assist in the performance assessment of professional soccer players.48
Keywords: skeletal muscle; performance; cytokines.49
50
51
52
53
54
55
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Introduction56
Myokines are cytokines produced by skeletal muscles, especially induced by exercise, 57
modulating different metabolic processes [6]. By influencing metabolism locally in the 58
muscles, myokines are thought to be involved in the whole-body metabolic adaptive 59
changes that occur in response to regular exercise like, for example, attenuation of fat 60
accumulation [2]. Skeletal muscle and pancreas act in a synergistic manner to monitor 61
systemic glucose homeostasis, and it has been suggested that myokines mediate the 62
cross-talk between insulin-sensitive tissues [17]. Striated skeletal muscle is one of the 63
body’s largest tissues. However, it is unclear how contracting skeletal muscles transmit64
metabolic positive effects on health. One of the possible explanations for the health 65
benefit of exercise can be that regular muscle contractions produce important 66
messengers such as myokines [5]. Released circulating myokines may explain how 67
normal muscle activity influences mood, physical performance and cognitive function68
[14].69
It has been shown that exercise up-regulates the expression of the newly described 70
myokine apelin in patients with type 2 diabetes [11]. In addition, apelin expression is 71
induced by exercise and secreted in vitro in human primary myotubes, and may behave 72
as a novel exercise-regulated myokine with autocrine/paracrine action [4]. Apelin is also 73
up-regulated by insulin, contributing thus to glucose homeostasis [19]. Finally, apelin is 74
highly implicated in cardiovascular function [10].75
Adropin is also a recently described myokine involved in the regulation of lipid 76
metabolism. It was first isolated in 2008 by Kumar et al. in liver and brain tissues [12]. 77
In mice, adropin regulates physical activity (locomotion and coordination) via the NB-78
3/Notch signaling pathway [20]. Elevated circulating levels of adropin reduce insulin 79
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resistance and glucose intolerance that arise in response to metabolic stress [7]. In this 80
case, there is no clear evidence about whether exercise can regulate circulating levels of 81
this myokine.82
Therefore, because myokines are clearly involved in exercise-associated metabolic and 83
cardiac changes, and hence could be potentially implicated in performance 84
improvements throughout a soccer season, we aimed to analyze the fluctuations of 85
circulating apelin and adropin levels in professional soccer players during a season. In 86
addition, we also evaluated the possible association of both myokines with the 87
performance level.88
Material and methods89
Subjects90
Fifteen male professional soccer players from an Italian Serie A team (age (mean±SD) 91
27±5 years, weight 76.9±4.1 kg, height 1.82±0.05 m, body fat 8.7±2.4 %) were included 92
in this study. Goalkeepers were not considered in this study since their physical load93
during soccer games is different from the other field players and as such their training 94
programs are also different. All participants were informed of the purpose, protocol, and 95
procedures of the study before agreeing to participate. The study complies with the 96
World Medical Association Declaration of Helsinki regarding ethical conduct of 97
research involving human subjects and/or animals and was approved by the ethics 98
committee of University of Valencia, and by the soccer clubs involved.99
Experimental Protocol100
The players were sampled 3 times during the last part of a competitive season (in 101
January, in March, in May). The competitive season finished at the end of May. 102
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Thereafter, all players took a vacation and returned to the team discipline at the 103
beginning of July, when the players included in the study were sampled again (just 104
before preseason training beginning). At all sampling points, both mokines were105
assessed along with the physical performance determinations. An extensive biochemical 106
and hematological profile study was also performed at all time-points but at May.107
Physical performance determinations108
At all time-points, the players were subjected to three physical performance tests, a 109
continuous running test (Mognoni’s Test) [8], a high-intensity intermittent test (HIT) 110
[18] and a counter-movement jump (CMJ) test.111
During the Mognoni’s Test, blood lactate (La-) concentration was determined 112
immediately after a single 6-min run at 13.5 km·h-1 while the mean heart rate (HR) of 113
the last minute of running was considered for the analysis. After 10-min of passive 114
recovery, subjects completed, following an acoustic signal, a HIT protocol (total 115
duration = 5 min) consisting of 10 x 10 s shuttle running at 18 km·h-1 'over a 25-m 116
course with an 180° direction change from run to run and 20s of passive recovery 117
between runs. Immediately after the HIT protocol, blood La- concentration was 118
determined and the mean HR of 5-min run was considered for the analysis.119
During both tests, blood La- accumulation was measured using a portable amperometric 120
microvolume lactate analyzer (Lactate Plus, Nova Biomedical, Waltham, MA, USA). 121
Capillary blood samples (0.7 µl) were collected from the earlobe. Before the tests, the 122
analyzer was calibrated following the instructions of the manufacturer. HR data was 123
collected using Polar Team2 Pro system (Kempele, Finland).124
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The CMJ test was performed using a portable force platform (Quattro Jump, Kistler, 125
Switzerland). In short, after a standardized warm-up, the subjects performed 6 single 126
CMJ and jump height and peak power output (PPO), averaged from the 3 best jumps 127
were recorded.128
In addition, the body fat percentage was estimated at all time points by the skin-fold 129
technique, based on the Jackson and Pollock formula [9]. 130
Blood sampling131
Blood collection and sample management before analysis was carried out strictly 132
following the good laboratory practice for pre-analytical phase of sports biochemistry 133
and hematology tests [3]. The samples were drawn by venipuncture in the antecubital 134
vein in fasting conditions. For hematological determinations, blood was collected in 135
K3EDTA vacuum tubes (Vacutainer, BD, Franklin Lakes, NJ, USA) and for 136
biochemical tests, in vacuum plain tubes without additives (Vacutainer). The former 137
were allowed to coagulate, then centrifuged at 3000 g for 10 min at room temperature 138
and after centrifugation, serum was separated into aliquots. Whole blood tubes were 139
immediately kept refrigerated at 4° C and assayed within 24 hours. Serum aliquots were 140
frozen at -80 °C until the assay.141
Laboratory Methods142
Adropin and apelin were determined in serum samples using available commercial 143
competitive enzyme-linked immunosorbent assay kits (CSB-EL007669HU, Cusabio, 144
Wuhan, China and EIA-APC, RayBiotech, Norcross, GA, USA; respectively). Both 145
assays were performed in duplicate following manufacturer’s instructions. Intra-assay 146
coefficients of variation were 13.92% for adropin and 4.52% for apelin determinations.147
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Full blood cell count was carried out on the automated analyzer XE-2100L (Sysmex, 148
Kobe, Japan). Creatine kinase (CK) and lactate dehydrogenase (LDH) activity as well 149
as iron, transferrin and high-sensitivity C-Reactive protein (hsCRP) concentration were 150
determined on the automated clinical chemistry platform ADVIA 1800 (Siemens 151
Healthcare Diagnostics, Erlangen, Germany), employing proprietary reagents. Cortisol 152
and testosterone were immunoassayed on the automated analyzer Elecsys 1010 (Roche 153
Diagnostics, Mannhein, Germany) using the dedicated electro-chemiluminescence 154
immunoassay kits. Ferritin was assayed on automated immunoassay system (ADVIA 155
Centaur) and soluble transferrin receptor (sTfR) on a fully automated 156
immunonephelometer (BN ProSpec), both provided by Siemens Healthcare Diagnostics157
and by using proprietary immunoassays. For calculation of the testosterone/cortisol ratio158
(FTCR), free testosterone was assumed as 2% of the total testosterone, and the formula 159
previously validated was adopted [1]. Also the total iron binding capacity (TIBC) was 160
estimated by applying the formula [TIBC (µg/dL) = transferrin (g/L) x 140] derived 161
from the stoichiometric relationship between divalent transferrin and iron.162
Statistical analysis163
All data were analyzed for normality by Shapiro-Wilk test. Since the majority of the 164
variables were not normally distributed, non-parametric tests were adopted. The effect 165
of training and detraining (sampling time: January, March, May and July) on the 166
parameters tested was analyzed with the Friedman’s test (χ2) and paired comparisons167
were performed with the Wilcoxon’s test (z). The Spearman’s coefficient (ρ) was used 168
to explore the correlation between adropin and apelin levels as well as with the other 169
parameters determined. The statistical analyses were performed using SPSS, version 21 170
(IBM Corporation, Armonk, NY, USA). The results were considered statistically 171
significant at p ≤ 0.05. Data were expressed as median (10th-90th percentile).172
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Results173
The aerobic endurance, assessed by post-exercise La- levels in Mognoni’s and HIT tests 174
changed at the end part of the competitive season and by the detraining period 175
[Mognoni χ2(3)=19.53, p<0.001; HIT χ2(3)=15.53, p=0.001; see Figure 1]. In the 176
Mognoni’s test, La- levels in January [3.50(2.55-6.82) mM] were higher than in March 177
[2.85(2.02-5.33) mM, z=-2.552, p=0.011] and in May [3.02(2.08-4.66) mM, z=-2.601, 178
p=0.009]. In the same line, La- levels in the HIT test in March [2.47(1.37-6.21) mM]179
were lower than in January [4.40(1.65-8.35) mM, z=-2.045, p=0.041] and May 180
[3.65(1.52-6.07) mM, z=-2.090, p=0.002]. This data would indicate a progressive 181
adaptation with training. However, the July La- values were higher in both tests (see 182
Figure 1) which would reflect the detraining occurring during the vacation period 183
between the end of the season and the beginning of the next pre-season. Accordingly, 184
the cardiovascular implication was higher after the detraining period in both Mognoni’s 185
[χ2(3)=13.00, p=0.005] and HIT [χ2(3)=11.44, p=0.010] tests (see Figure 1). 186
Nevertheless, we failed to find any significant effect of training and detraining on either187
jump height [χ2(3)=5.23, p=0.156] or PPO [χ2(3)=1.46, p=0.692] in the CMJ test.188
Figure 2 shows a significant increase in the apelin concentration from 341.8(283.0-189
444.8) ng/mL in January to 433.3(373.4-677.5) ng/mL in March. Nonetheless, no 190
statistically significant changes were found in either May or July compared to the 191
previous time points. No significant changes were observed in adropin at any time.192
A full blood cell panel along with several biochemical parameters was performed in193
January, March and July sampling times, but it could not be performed in May. These 194
data are displayed on Table 1. The detraining period induced some alterations in 195
erythrocyte indices. The mean corpuscular volume decreased while mean corpuscular 196
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hemoglobin increased in July in comparison with the previous sampling points (Table 197
1). The red blood distribution width was slighter lower in July compared with January 198
levels (z=-2.284, p=0.022, Table 1). HsCRP, an inflammatory marker, was found to be 199
lower in July compared to January (z=-2.528, p=0.011). After detraining, levels of both 200
biomarkers of muscle damage CK and LDH, were significantly lower compared with 201
the previous time points (see Table 1).202
Players’ weight [January 77.0 (69.8-82.3) kg, March 77.0(69.0-83.5) kg, May 203
76.5(68.0-84.8) kg and July 77.6(70.1-86.9) kg)] and percentage of body fat [January 204
8.4(5.8-13.1) %, March 8.1(6.5-12.0) %, May 8.2(5.5-12.0) %, July (9.2(7.0-12-4) %] 205
did not significantly change at the end of the competitive season or after the detraining 206
period [χ2(3)=6.126, p=0.106; χ2(3)=4.576, p=0.206; respectively].207
Finally, no correlation was found between adropin or apelin concentrations and 208
performance parameters at all time points measured (Supplementary Table 1). On the 209
other hand, significant correlations were found between adropin and apelin levels and 210
other hematological and biochemical parameters measured (Supplementary Table 2), 211
although those correlations did not provide additional insights.212
Discussion213
No significant changes were observed in adropin levels, while apelin exhibited 214
variations that seem not to be related with performance. On the other hand, the patterns 215
of changes in the biomarkers of fatigue and inflammation, i.e., HsCRP, CK and LDH 216
reflected the effects of the training throughout the season.217
While apelin levels showed a significant increase only in the first time point, possibly 218
linked to an increased effort, fluctuations in adropin levels did not reach statistical219
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significance. In both cases, however, the distribution widths within the study cohort220
were large: this was particularly true in the case of adropin but was also evident for 221
apelin at the end of the season and after the rest period. It thus seems that the use of 222
these two markers is not useful to assist in the performance assessment of professional 223
soccer players. It should be also mentioned that, while other myokines seem to be 224
relatively stable within person [13-16] thereby allowing longitudinal analyses, there is225
paucity of such data on apelin and adropin.226
The main limitation of our study is the low number of subjects included on each 227
experimental group that can decrease the power of the statistical analyses performed.228
Since season openings in Europe are regularly at mid/late August, we did not have a 229
first season's start sample to compare. In addition, the specific design of this study with 230
only professional athletes recruited limits the generalizability of its results in less 231
trained individuals. Moreover, due to a problem of samples conservation, the232
hematological and biochemical panel could not be determined at May. Nevertheless, 233
this study needs to be evaluated in both larger and different cohorts before they can be 234
translated into clinical practice.235
In conclusion, a one-season follow-up of professional soccer player's training did not 236
lead to observe changes in circulating apelin and adropin levels. Accordingly, neither 237
apelin nor adropin were associated with changes in performance level.238
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Table and Figures Legends
Table 1. Players’ hematological and biochemical parameters in January, March, and 
July (i.e., at the beginning of the next pre-season).
Figure 1. Blood lactate (La-) and heart rate (HR) in the Mognoni and HIT protocols, 
and height jump and peak power output in the counter-movement jump test (CMJ) 
during the competitive season (January, March and May) and in the next pre-season 
stage (July). During the Mognoni’s Test, La- concentration was determined immediately 
after the test, while the mean HR of the test’s last minute of running was considered. 
During the HIT protocol La- concentration was determined just after the test and the 
mean HR of 5-min run was considered. CMJ height and peak power output was 
averaged from the 3 best of 6 jump repetitions. Data represented as median (horizontal 
line), 1st to 3rd quartile (box) and 10th to 90th percentile (whiskers). Significant 
comparisons are indicated. 
Figure 2. Apelin and adropin concentrations during the competitive season (January, 
March and May) and in the next pre-season stage (July). Data represented as median 
(horizontal line), 1st to 3rd quartile (box) and 10th to 90th percentile (whiskers). 
Significant comparisons are indicated.
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Table 1. 
In-season
January
In-season
March
Pre-season
July
Friedman’s
p-value
RBC (x106/µL) 5.03(4.60-5.73) 5.12(4.78-5.45) 5.11(4.72-5.87) 0.247
Hemoglobin (g/dL) 15.1(13.8-16.0) 15.3(14.3-16.2) 15.1(13.7-16.7) 0.302
Hematocrit (%) 44.0(41.0-47.3) 44.5(42.0-46.8) 44.9(40.1-47.7) 0.591
MCV (fL) 87.2(81.9-89.6)*** 85.9(83.0-91.2)*** 84.7(80.9-88.4) <0.001
MCH (pg) 30.0(27.9-31.2)* 30.1(27.9-31.1)**,# 29.5(27.8-30.9) <0.001
MCHC (g/dL) 34.3(33.1-35.5) 34.5(33.2-35.9) 34.5(33.2-36.6) 0.581
RDW (%) 13.0(12.5-13.5)* 12.9(12.4-13.5) 12.8(12.3-13.6) 0.011
Reticulocytes (%) 0.67(0.51-1.02)** 0.66(0.43-0.88)** 0.82(0.57-1.33) 0.005
IRF (%) 3.2(1.44-5.98) 2.8(0.94-6.28) 3.2(1.26-5.78) 0.721
Fe (µg/dL) 82(60-117) 96(58-131) 84(67-145) 0.627
Ferritin (ng/mL) 125.7(69.1-246.7) 130.2(48.7-244.7) 113.4(51.6-217.6) 0.070
Transferrin (mg/dL) 249(213-273) 242(211-290) 259(207-297) 0.085
TIBC (µg/dL) 349(299-383) 339(296-405) 363(290-416) 0.085
Transferrin saturation (%) 25(18-32) 26(18-41) 26(18-39) 0.349
sTfR (mg/L) 1.30(0.84-1.63) 1.15(0.90-1.49) 1.19(0.83-1.62) 0.591
WBC (x103/µL) 4.97(4.01-6.52) 4.70(3.89-7.5) 5.01(4.25-7.76) 0.516
Lymphocytes (x103/µL) 2.2(1.4-3.3) 2.1(1.5-2.9) 2.3(1.6-3.0) 0.272
Neutrophils (x103/µL) 2.3(1.4-2.9) 2.4(1.4-4.1) 2.3(1.5-3.9) 0.179
Monocytes (x103/µL) 0.4(0.3-0.6) 0.4(0.3-0.6) 0.4(0.3-0.6) 0.971
Basophils (x103/µL) 0.02(0.01-0.03) 0.02(0.01-0.04) 0.02(0.01-0.03) 0.928
Eosinophils (x103/µL) 0.1(0.1-0.4)** 0.1(0.1-0.5) 0.2(0.1-0.5) 0.009
hsCRP (mg/L) 0.97(0.40-8.22)* 0.71(0.16-2.25) 0.30(0.13-2.49) 0.022
Creatine kinase (U/L) 392(240-2053)** 382(168-713)* 294(125-925) <0.001
Lactate dehydrogenase (U/L) 205(73-271)* 190(148-231)*,# 158(127-217) <0.001
Cortisol (ng/mL) 238.0(190.3-277.4) 214.9(183.9-271.7) 214.1(135.2-260.1) 0.165
Testosterone (ng/mL) 7.21(4.15-9.57) 7.61(5.39-9.34) 7.16(5.39-9.95) 0.766
FTCR 0.74(0.47-0.95) 0.82(0.58-0.99) 0.91(0.61-1.57) 0.241
RBC: red blood cell. MCV: mean corpuscular volume. MCH: mean corpuscular hemoglobin. MCHC: 
mean corpuscular hemoglobin concentration. RDW: red blood cell distribution width. IRF: non-
mature reticulocyte fraction. sTfR: soluble transferrin receptor. TIBC: total iron-binding capacity. 
WBC: white blood cell. hsCRP: high-sensitivity C-Reactive protein. FTCR: free-testosterone to 
cortisol ratio. Data as median (10th-90th percentile).
*p<0.05, **p<0.01 and ***p<0.001 vs July. #p<0.05, ##p<0.01 and ###p<0.01 vs January.
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Highlights
 Myokines are involved in metabolic adaptive changes induced by regular 
exercise.
 We investigated the association of two myokines (adropin and apelin) with 
physical performance.
 No significant changes were observed in adropin.
 Apelin exhibited variations that seem not to be related with performance.
 Apelin and adropin levels are not related to performance in professional soccer 
players.
Page 17 of 18
Ac
ce
pte
d M
an
us
cri
pt
Figure 1
Page 18 of 18
Ac
ce
pte
d M
an
us
cri
pt
Figure 2
